B. Gay Elisha

895 total citations
23 papers, 588 citations indexed

About

B. Gay Elisha is a scholar working on Molecular Biology, Molecular Medicine and Infectious Diseases. According to data from OpenAlex, B. Gay Elisha has authored 23 papers receiving a total of 588 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Molecular Medicine and 8 papers in Infectious Diseases. Recurrent topics in B. Gay Elisha's work include Antibiotic Resistance in Bacteria (12 papers), Bacterial Genetics and Biotechnology (7 papers) and Bacteriophages and microbial interactions (5 papers). B. Gay Elisha is often cited by papers focused on Antibiotic Resistance in Bacteria (12 papers), Bacterial Genetics and Biotechnology (7 papers) and Bacteriophages and microbial interactions (5 papers). B. Gay Elisha collaborates with scholars based in South Africa, France and United Kingdom. B. Gay Elisha's co-authors include Heidi Segal, Patrice Courvalin, Andrew Whitelaw, Maitshwarelo Matsheka, Melissa J. Jansen van Rensburg, Albert J. Lastovica, Lafras M. Steyn, Mkunde Chachage, Sumayya Haffejee and Stephen L. W. On and has published in prestigious journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy and Gene.

In The Last Decade

B. Gay Elisha

23 papers receiving 566 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Gay Elisha South Africa 12 353 240 186 132 117 23 588
Herin Oh Sweden 6 416 1.2× 162 0.7× 145 0.8× 73 0.6× 65 0.6× 6 550
Zorica Lepšanović Serbia 11 266 0.8× 192 0.8× 212 1.1× 192 1.5× 67 0.6× 35 540
Supathep Tansirichaiya United Kingdom 7 352 1.0× 225 0.9× 166 0.9× 99 0.8× 143 1.2× 17 637
Lianwei Ye Hong Kong 15 528 1.5× 233 1.0× 236 1.3× 70 0.5× 98 0.8× 56 707
Gongzheng Hu China 15 474 1.3× 146 0.6× 181 1.0× 80 0.6× 129 1.1× 61 650
Fen Qu China 15 246 0.7× 127 0.5× 184 1.0× 160 1.2× 63 0.5× 35 556
Dhiviya Prabaa Muthuirulandi Sethuvel India 17 418 1.2× 184 0.8× 301 1.6× 161 1.2× 160 1.4× 42 715
Érica L Fonseca Brazil 15 438 1.2× 185 0.8× 310 1.7× 61 0.5× 153 1.3× 45 680
Susana Correia Portugal 6 291 0.8× 146 0.6× 83 0.4× 95 0.7× 80 0.7× 6 548
Yushan Pan China 14 424 1.2× 141 0.6× 152 0.8× 70 0.5× 123 1.1× 46 578

Countries citing papers authored by B. Gay Elisha

Since Specialization
Citations

This map shows the geographic impact of B. Gay Elisha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Gay Elisha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Gay Elisha more than expected).

Fields of papers citing papers by B. Gay Elisha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Gay Elisha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Gay Elisha. The network helps show where B. Gay Elisha may publish in the future.

Co-authorship network of co-authors of B. Gay Elisha

This figure shows the co-authorship network connecting the top 25 collaborators of B. Gay Elisha. A scholar is included among the top collaborators of B. Gay Elisha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Gay Elisha. B. Gay Elisha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moodley, Vineshree Mischka, et al.. (2013). Evaluation of Five Susceptibility Test Methods for Detection of Tobramycin Resistance in a Cluster of Epidemiologically Related Acinetobacter baumannii Isolates. Journal of Clinical Microbiology. 51(8). 2535–2540. 6 indexed citations
2.
Rensburg, Melissa J. Jansen van, Andrew Whitelaw, & B. Gay Elisha. (2012). Genetic basis of rifampicin resistance in methicillin-resistant Staphylococcus aureus suggests clonal expansion in hospitals in Cape Town, South Africa. BMC Microbiology. 12(1). 46–46. 22 indexed citations
3.
Rensburg, Melissa J. Jansen van, et al.. (2010). The dominant methicillin‐resistant Staphylococcus aureus clone from hospitals in Cape Town has an unusual genotype: ST612. Clinical Microbiology and Infection. 17(5). 785–792. 34 indexed citations
4.
Bhakta, Sanjib, Angela J. Russell, William E. Campbell, et al.. (2007). Inhibition of mycobacterial arylamine N-acetyltransferase contributes to anti-mycobacterial activity of Warburgia salutaris. Bioorganic & Medicinal Chemistry. 15(10). 3579–3586. 42 indexed citations
5.
Segal, Heidi & B. Gay Elisha. (2006). Identification and characterization of an aadB gene cassette at a secondary site in a plasmid from Acinetobacter. FEMS Microbiology Letters. 153(2). 321–326. 6 indexed citations
6.
Matsheka, Maitshwarelo, Albert J. Lastovica, Harold Zappe, & B. Gay Elisha. (2006). The use of (GTG)5 oligonucleotide as an RAPD primer to type Campylobacter concisus. Letters in Applied Microbiology. 0(0). 1848062278–1848062278. 16 indexed citations
7.
Segal, Heidi, et al.. (2005). Is ISABA-1customized forAcinetobacter?. FEMS Microbiology Letters. 243(2). 425–429. 129 indexed citations
8.
Segal, Heidi, et al.. (2004). Genetic Environment and Transcription of ampC in an Acinetobacter baumannii Clinical Isolate. Antimicrobial Agents and Chemotherapy. 48(2). 612–614. 56 indexed citations
10.
Whitelaw, Andrew, et al.. (2002). Use of 16S rRNA Sequencing for Identification of Actinobacillus ureae Isolated from a Cerebrospinal Fluid Sample. Journal of Clinical Microbiology. 40(2). 666–668. 4 indexed citations
11.
Cooper, R.G., Heidi Segal, Albert J. Lastovica, & B. Gay Elisha. (2002). Genetic basis of quinolone resistance and epidemiology of resistant and susceptible isolates of porcine Campylobacter coli strains. Journal of Applied Microbiology. 93(2). 241–249. 18 indexed citations
12.
Matsheka, Maitshwarelo, et al.. (2002). Genetic heterogeneity ofCampylobacter concisusdetermined by pulsed field gel electrophoresis-based macrorestriction profiling. FEMS Microbiology Letters. 211(1). 17–22. 25 indexed citations
13.
Matsheka, Maitshwarelo, Albert J. Lastovica, & B. Gay Elisha. (2001). Molecular Identification of Campylobacter concisus. Journal of Clinical Microbiology. 39(10). 3684–3689. 10 indexed citations
15.
Elisha, B. Gay & Patrice Courvalin. (1995). Analysis of genes encoding d-alanine: d-alanine ligase-related enzymes in Leuconostoc mesenteroides and Lactobacillus spp.. Gene. 152(1). 79–83. 54 indexed citations
17.
Elisha, B. Gay & Lafras M. Steyn. (1994). High level kanamycin resistance associated with the hyperproduction of AAC(3)II and a generalised reduction in the accumulation of aminoglycosides in Acinetobacter spp. Journal of Antimicrobial Chemotherapy. 34(4). 457–464. 4 indexed citations
18.
Elisha, B. Gay & Lafras M. Steyn. (1991). Identification of an Acinetobacter baumannii gene region with sequence and organizational similarity to Tn2670. Plasmid. 25(2). 96–104. 9 indexed citations
19.
Elisha, B. Gay & Lafras M. Steyn. (1991). Cloning of AAC(3) and AAD(2″) genes fromAcinetobacter: differential expression in the host strain. Current Microbiology. 22(4). 259–263. 4 indexed citations
20.
Elisha, B. Gay & Lafras M. Steyn. (1989). Aminoglycoside-O-phosphotransferase (APH (3'')) activity in a clinical isolate of Acinetobacter calcoaceticus.. PubMed. 75(5). 220–2. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026